Skip to main content
. Author manuscript; available in PMC: 2024 Mar 8.
Published in final edited form as: ASSETS. 2023 Oct 22;2023:23.

Table 1:

Participants’ characteristics.

ID Age Gender Diagnosis CVL VA (logMAR) Expert
P1 57 F Stargardt disease Y 1.04 Y
P2 69 M X-linked retinoschisis Y 1 N
P3 86 M Age-related macular degeneration Y 0.62 N
P4 28 F Congenital glaucoma + 2° nystagmus Y 0.76 Y
P5 61 M Retinitis pigmentosa N 0.42 N
P6 71 M Optic nerve atrophy N 1.04 Y
P7 69 M Age-related macular degeneration Y 0.26 N
P8 74 F Age-related macular degeneration Y 1 Y
P9 54 M Retinopathy of prematurity N 0.7 N
P10 82 F Glaucoma N 0.38 N
P11 47 M Ocular albinism N 0.72 N
P12 31 M Achromatopsia N 0.9 Y
P13 93 F Age-related macular degeneration Y 0.36 N
P14 42 M Congenital nystagmus N 0.44 Y
P15 37 F Retinopathy of prematurity N 0.42 N
P16 71 F Glaucoma Y 0.3 Y
P17 85 M Glaucoma N 0.5 Y
P18 68 M Oculocutaneous albinism N 0.6 Y
P19 55 F Optic neuritis N 0.4 Y
P20 95 M Age-related macular degeneration Y 0.8 N

CVL: Central Vision Loss. VA: Visual Acuity in better eye (measured in logMAR units). Expert: Uses some form of screen magnification on a regular basis.